Consistent Long-Term Therapy of Neovascular Age-Related Macular Degeneration Managed by 50 or More Anti-VEGF Injections Using a Treat-Extend-Stop Protocol
Keywords: ANCHOR; Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration; AMD; age-related macular degeneration; CATT; Comparison of Age-Related Macular Degeneration Treatments Trial; CNV; chor